Substituted polycyclic aryl and heteroaryl pyrazinones...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 241/20 (2006.01) A61K 31/495 (2006.01) A61P 7/02 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/04 (2006.01) C07D 409/04 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07K 5/06 (2006.01) C07K 5/078 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2409445

The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.

L'invention concerne des composés d'aryle polycyclique substitué et de pyrazinone d'hétéroaryle utilisés comme inhibiteurs des sérine protéases de la coagulation, et des composés, des compositions et des méthodes destinés à la thérapie d'anticoagulation permettant de traiter et de prévenir plusieurs affections thrombotiques, notamment des maladies des artères coronariennes et cérébrovasculaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted polycyclic aryl and heteroaryl pyrazinones... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted polycyclic aryl and heteroaryl pyrazinones..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted polycyclic aryl and heteroaryl pyrazinones... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2008668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.